Imexpharm

Imexpharm Payout Ratio

The Dividend Payout Ratio of Imexpharm (IMP.VN) as of Oct 27, 2026 is 22.06 %. In the previous year, Dividend Payout Ratio was 24.00 % — a change of -8.10% (lower).

Payout Ratio

22.06 %

YoY

-8.10%

Last updated:

Dividend Payout Ratio of Imexpharm is 2025 22.06 % . Dividend Payout Ratio of Imexpharm was 2024 24.00 % . It decreases by -8.10% lower compared to the previous year.

The payout ratio is around 22% of earnings.

The Imexpharm Payout Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Payout Ratio
Date
Payout Ratio
Jan 1, 2020
13.76 VND
Jan 1, 2021
22.89 VND
Jan 1, 2022
19.37 VND
Jan 1, 2023
10.62 VND
Jan 1, 2024
24.00 VND
Jan 1, 2025
22.06 VND
Jan 1, 2026 (e)
23.74 VND
Jan 1, 2027 (e)
20.48 VND
The Imexpharm Payout Ratio history
YEARPayout RatioYoY
est20.48 %-13.74%
est23.74 %+7.64%
22.06 %-8.10%
24.00 %+125.93%
10.62 %-45.15%
19.37 %-15.41%
22.89 %+66.34%
13.76 %-47.73%
26.33 %+39.38%
18.89 %-15.34%
22.32 %-19.07%
27.57 %-1.96%
28.12 %+193.38%
9.59 %-46.56%
17.94 %-14.82%
21.06 %+54.98%
13.59 %-79.26%
65.53 %+63.32%
40.12 %-70.44%
135.74 %+253.93%
38.35 %+103.01%
18.89 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Imexpharm Stock analysis

What does Imexpharm do? Imexpharm Corp manufactures and trades pharmaceuticals, medicinal chemicals, and botanical products, including antiseptics, traditional medicine, medical equipment, cosmetics, and supplemental food and drinks. The company provides packaging and warehousing services specifically for pharmaceutical storage. It also cultivates medicinal herbs. Imexpharm Corp serves the pharmaceutical industry and healthcare sector through its manufacturing, import, export, and trade operations, targeting businesses requiring medicinal products and services. The company's revenue streams include the sale of manufactured pharmaceuticals, imported and exported goods, and services such as packaging and warehousing. Its customers are businesses in the healthcare sector, including distributors and retailers of pharmaceuticals, medical equipment, and related products. The firm's operations span manufacturing, import, export, and trade, with additional services supporting the pharmaceutical supply chain. Imexpharm Corp's product portfolio covers a wide range of medicinal and health-related items, from antiseptics to supplemental food and drinks. The company's involvement in medicinal herb cultivation supports its production of traditional medicine and herbal-based products. This vertical integration enhances its ability to supply comprehensive solutions to healthcare businesses. Imexpharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Imexpharm stock

Dividend Payout Ratio of Imexpharm is 22.06 % in 2025.

Dividend Payout Ratio of Imexpharm changed from 24.00 % to 22.06 %, representing a -8.10% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Dividend Payout Ratio Imexpharm since 2006 – with annual values, charts, and detailed analysis.

The payout ratio measures the percentage of net income distributed as dividends. A sustainable payout ratio leaves room for reinvestment and growth.

Dividend Payout Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Payout Ratio's Imexpharm historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Imexpharm

All Key Metrics — Imexpharm